Evidence map›Paper›PMID 23224090›Full record

ArticleJournal of clinical microbiology2013

Multiple-locus variable-number tandem-repeat analysis of 201 Mycoplasma pneumoniae isolates from Beijing, China, from 2008 to 2011.

Fei Zhao, Gang Liu, Bin Cao, Jiang Wu, Yixin Gu, Lihua He, Fanliang Meng, Liang Zhu, Yudong Yin, Min Lv and 1 more

Abstract read
In one paragraph

Article in Journal of clinical microbiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Article
  3. Increased Macrolide Resistance Rate of M3562Frontiers in cellular and infection microbiology · 2021
    Article
  4. Molecular characterization of Mycoplasma pneumoniae infections in Moscow from 2015 to 2018.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2020
    Article
  5. Periodic Genotype Shifts in Clinically PrevalentFrontiers in cellular and infection microbiology · 2020
    Article
  6. Article
  7. Antimicrobial susceptibility and molecular characteristics ofAntimicrobial resistance and infection control · 2019
    Article
  8. Antimicrobial susceptibility and genotyping ofAntimicrobial resistance and infection control · 2019
    Article
  9. Journal of clinical medicine research · 2018
    Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Fei ZhaoNational Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, State Key Laboratory for Infectious Disease Prevention and Control, Beijing, China.
Gang Liu
Bin Cao
Jiang Wu
Yixin Gu
Lihua He
Fanliang Meng
Liang Zhu
Yudong Yin
Min Lv
Jianzhong Zhang

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A total of 201 Mycoplasma pneumoniae clinical isolates from Beijing, China, isolated from 2008 to 2011, were clustered into 16 multiple-locus variable-number tandem-repeat analysis (MLVA) types, of which 6 new MLVA types have never been reported previously. Type 1 isolates based on p1 gene genotyping were mainly MLVA types E, J, P, U, and X. There was no correlation between macrolide-resistant Mycoplasma pneumoniae and their MLVA type.

Indexed as

Multilocus Sequence TypingChinaCluster AnalysisGenes, BacterialGenotypeHumansMinisatellite RepeatsMycoplasma pneumoniaePneumonia, MycoplasmaRNA, Ribosomal, 23SRNA, Ribosomal, 23S

Identifiers

PMID23224090
PMCPMC3553874

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.